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Inflammatory bowel diseases (IBD) encompass at least two forms of intestinal inflammation: 
Crohn's disease and ulcerative colitis (UC). Both conditions are chronic and inflammatory 
disorders in the gastrointestinal tract, with an increasing prevalence being associated with the 
industrialization of nations and in developing countries. Patients with these disorders are 10 to 
20 times more likely to develop cancer of the colon. The aim of this study was to characterize 
the effects of a naturally occurring polyphenol, gallic acid (GA), in an experimental murine 
model of UC. A significant blunting of weight loss and clinical symptoms was observed in 
dextran sodium sulfate (DSS)-exposed, GA-treated mice compared with control mice. This 
effect was associated with a remarkable amelioration of the disruption of the colonic 
architecture, a significant reduction in colonic myeloperoxidase (MPO) activity, and a decrease 
in the expression of inflammatory mediators, such as inducible nitric oxide synthase (iNOS), 
cyclooxygenase (COX)-2, and pro-inflammatory cytokines. In addition, GA reduced the 
activation and nuclear accumulation of p-STAT3Y705, preventing the degradation of the 
inhibitory protein IκB and inhibiting of the nuclear translocation of p65-NF-κB in colonic 
mucosa. These findings suggest that GA exerts potentially clinically useful anti-inflammatory 
effects mediated through the suppression of p65-NF-κB and IL-6/p-STAT3Y705 activation. 
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